Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianyao Pharmaceutical is a leading Chinese pharmaceutical enterprise and a global powerhouse in the production of corticosteroid drugs. The company specializes in the research, development, and large-scale manufacturing of synthetic steroid hormones, including active pharmaceutical ingredients (APIs) and finished formulations such as tablets, injections, and ointments. It is recognized as one of the world's largest suppliers of dexamethasone and prednisone, maintaining a dominant market share across more than 70 countries. Tianyao operates vertically integrated, high-standard GMP facilities and is a core subsidiary of the Tianjin Pharmaceutical Group. Its business model combines robust chemical synthesis capabilities with a broad portfolio of generic and essential medicines serving immunology, endocrinology, and respiratory health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianyao Pharmaceuticals.